FDA Works to Ensure Smooth Regulatory Transition of Insulin and Other Biological Products - FDA Press Releases

Today, the U.S. Food and Drug Administration took additional steps to ensure a smooth regulatory transition aimed at increasing patient access to insulin products, as well as certain other biological products set to transition regulatory pathways in March

from FDA Press Releases RSS Feed https://ift.tt/2V9KINA
via IFTTT